With over 40 years’ experience in the pharmaceutical industry Harry has built two successful publicly listed pharmaceutical companies. He acts as non executive director for a number of pharmaceutical companies, both public and private.
Harry founded Shire Plc in 1986 and was CEO for almost a decade. Shire Plc grew from humble beginnings to be one of Europe’s largest specialty pharmaceutical companies and its stock is a constituent of the FTSE100 index. Mr Stratford then went on to be founder, CEO and Executive Chairman of Prostrakan Plc, another international specialty pharmaceutical company, which was subsequently acquired by Kyowa Hakko Kirin of Japan in 2011.
Harry holds a BSc in Chemistry from the University of London and was awarded an OBE in the 2007 New Year’s Honours list for his contribution to the Scottish Life Sciences Industry.